Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet

Pharmaceutical Development and Technology

Volumn 16, Issue 5, 2011, Pages 449-456

  Kshirsagar, Sanjay J ^a   Bhalekar, Mangesh R ^a   Umap, Rajesh R ^b  

^a AISSMS COLLEGE OF PHARMACY   (India)

^b B J MEDICAL COLLEGE   (India)

Author keywords

Colonic drug delivery; Eudragit FS 30 D; Superdisintegrant; X ray studies

Indexed keywords

BARIUM SULFATE; DICLOFENAC; EUDRAGIT; EUDRAGIT FS 30 D; PLACEBO; STARCH GLYCOLATE SODIUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASCENDING COLON; COLON; CONTROLLED STUDY; DESCENDING COLON; DRUG COATING; DRUG FORMULATION; DRUG RELEASE; ENTERIC COATED TABLET; ENTERITIS; GASTROINTESTINAL RADIOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INTESTINE TRANSIT TIME; MALE; NORMAL HUMAN; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS; WEIGHT GAIN;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; CHEMISTRY, PHARMACEUTICAL; COLON; DICLOFENAC; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICROSCOPY, ELECTRON, SCANNING; POLYMETHACRYLIC ACIDS; RADIOGRAPHY; TABLETS, ENTERIC-COATED;

EID: 80052890033     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.485319     Document Type: Article

References (20)

1. Gupta VK, et al. A novel pH and time based multi potential colonic drug delivery system. Int J Pharm 2001;213:83-91. (Pubitemid 32119464)
2. Davis SS. Overcoming the barriers to the oral administration of peptide drugs. Trends Pharm Sci 1990;11:353-355. (Pubitemid 20262457)
3. Kinget R, et al. Colonic drug targeting. J Drug Targeting 1998;6:129-149. (Pubitemid 29033981)
4. Fazio L, et al. Association between colonic screening, subject characteristics and stage of colorectal cancer. Am. J Gastroenterol 2005;100:2531-2539.
5. Bresalier RS. Primary chemoprevention of familial adenoma-tous polyposis with sulindac: More questions than answers. Gastroenterology 2002;123(1):379-381.
6. Taha A. Famotidine for the prevention of gastric and duodenal ulcer caused by nonsteroidal anti-infammatory drugs. New Engl J Med 1996;334:1435-1439. (Pubitemid 26157439)
7. Cheng G, et al. Time and pH dependent colon specifc drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid. World J Gastroenterol 2004;10(12): 1769-1774. (Pubitemid 38931202)
8. Rodriguez M, et al. Design of a new multiparticulate system for potential site specifc and controlled drug delivery to the colonic region. J Controlled Release 1998;55:67-77. (Pubitemid 28477565)
9. Singh BN. Modifed-release solid formulations for colonic delivery. Recent Patents on Drug Deliv Formulat 2007;1:53-61.
10. Gao C, et al. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D coated pellets. Int J Pharm 2006;322:104-112. (Pubitemid 44331530)
11. Chorasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery system. J Pharm Pharmaceutical Sci 2002;6(1):33-66.
12. Ibekwe VC, Kendall RA, Basit AW. Drug delivery to the colon. Te Drug Delivery Companies Report Spring/Summer, 2004:27-30.
13. Lee H, Mukherjee S. Drug delivery-oral colon-specifc. In: Swarbrick J, Boylan J, editors. Encyclopedia of pharmaceutical technology. New York: Marcel Dekker, 2002:871-885.
14. Rudolf MW, et al. A new 5 aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. Eur J Pharm Biopharm 2001;51:183-190.
15. Basit A, Bloor J. Perspectives on colonic drug delivery. Business briefng: Pharmatech 2003:185-190.
16. Iruin A, et al. Elaboration and 'in vitro' characterization of 5-ASA beads. Drug Develop Ind Pharm 2005;31:231-239. (Pubitemid 40315718)
17. Maria LG, et al. In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. Eur J Pharm Sci 2003;20:125-131.
18. Huyghebaert N, Vermeire A, Remon, JP, et al. In vitro evaluation of coating polymers for enteric coating and human ileal targeting. Int J Pharmaceut 2005;298:26-37. (Pubitemid 40828326)
19. European Commission. Radiation Protecting 118 Referral Guidelines for Imaging. Luxembourg: Ofce for Ofcial Publications of the European Commission Directorate-General for the Environment. 2000. Accessed 20 July 2009 from the web site: http://europaeuint/comm/energy/nuclear/radioprotection/publication/ doc/118-enpdf.2000.
20. Friend DR. New oral delivery system for treatment of infammatory bowel disease. Adv Drug Deliv Rev 2005;57:247-265. (Pubitemid 39536101)